Patent details

EP2462242 Title: RESPONSIVENESS TO ANGIOGENESIS INHIBITORS

Basic Information

Publication number:
EP2462242
PCT Application Number:
PCT/EP/2010/004761
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP107445132
PCT Publication Number:
WO/2011/015348
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RESPONSIVENESS TO ANGIOGENESIS INHIBITORS
French Title of Invention:
SENSIBILITÉ AUX INHIBITEURS DE L'ANGIOGENÈSE
German Title of Invention:
ANSPRECHEMPFINDLICHKEIT AUF ANGIOGENESEHEMMER
SPC Number:

Dates

Filing date:
03/08/2010
Grant date:
01/04/2015
EP Publication Date:
01/04/2015
PCT Publication Date:
10/02/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/06/2012
EP B1 Publication Date:
01/04/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/08/2015
Expiration date:
03/08/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/08/2010
 
 

Name:
F.Hoffmann-La Roche AG
Address:
Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Name:
Life Sciences Research Partners VZW
Address:
Campus Gasthuisberg Herestraat 49, bus 913, 3000 Leuven, Belgium (BE)

Name:
VIB VZW
Address:
Rijvisschestraat 120, 9052 Gent, Belgium (BE)

Inventor

1

Name:
DELMAR Paul
Address:
Switzerland (CH)

2

Name:
SCHERER Stefan
Address:
Switzerland (CH)

3

Name:
LAMBRECHTS Diether
Address:
Belgium (BE)

4

Name:
FOERNZLER Dorothee
Address:
Switzerland (CH)

5

Name:
CARMELIET Peter
Address:
Belgium (BE)

Priority

Priority Number:
09167184
Priority Date:
04/08/2009
Priority Country:
European Patent Office (EPO) (EP)

Classification

Main IPC Class:
C12Q 1/68;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages